Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Molecules ; 28(9)2023 Apr 27.
Article in English | MEDLINE | ID: mdl-37175163

ABSTRACT

Based on the principle of molecular splicing and theory of traditional Chinese medicine pairs, a new multi-active compound (HM475) was synthesized by connecting metformin with honokiol, and its structure was characterized, which not only reduced the toxicity of raw materials, but also maintained the original activity, and had a certain significance in research and innovation. At the same time, quality control and preliminary activity evaluation were carried out, and the effect of HM475 on neuroinflammation was further explored, which provided a new idea for drug development of neurodegenerative diseases.


Subject(s)
Drugs, Chinese Herbal , Lignans , Medicine, Chinese Traditional , Quality Control , Biphenyl Compounds , Drug Development , Lignans/pharmacology
2.
J Food Sci ; 86(3): 779-791, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33598925

ABSTRACT

Pu-erh tea is believed to be a beneficial beverage for health due to its many kinds of pharmacological effects. Nevertheless, detailed information related to differences in metabolites of Pu-erh raw tea from different geographical origins remains scarce. In this study, 43 elements were found in water-soluble components of Pu-erh raw tea by highly sensitive ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry (U-HPLC/Q-TOF-MS). The characteristic groups of 29 metabolites from nondestructive proton nuclear magnetic resonance (1 H-NMR) spectroscopy were assigned. The variables contributed largely to the origin classification, mainly including valine, threonine, chlorogenic acid, quinic acid, epiafzelechin, and gallic acid ester, were screened out by sparse partial least squares discriminant analysis (sPLS-DA) method. This study provided a feasible and rapid technique for distinguishing Pu-erh tea from different areas by 1 H-NMR combined with sPLS-DA.


Subject(s)
Camellia sinensis/classification , Tea/classification , Camellia sinensis/chemistry , Catechin , Chromatography, High Pressure Liquid , Discriminant Analysis , Flavonoids/analysis , Least-Squares Analysis , Magnetic Resonance Spectroscopy , Mass Spectrometry , Plant Extracts/chemistry , Tea/chemistry
3.
Chem Biodivers ; 17(4): e1900684, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32064755

ABSTRACT

Anemarrhena asphodeloides Bunge is a traditional Chinese medicine. The timosaponin BII is one of the most abundant and widely studied active ingredients in Anemarrhena asphodeloides Bunge. Related studies have shown that timosaponin BII has potential value for development and further utilization. The protective effect of timosaponin BII on islet ß cells under type 2 diabetes was investigated in the glycolipid toxic INS-1 cell model and possible biomarkers were explored by lipidomics analysis. Timosaponin BII was isolated from Anemarrhena asphodeloides Bunge by polyamide resin and Sephadex LH-20. Then, the glycolipid toxicity INS-1 cell model was established to investigate the protective effect of timosaponin BII. The results showed that timosaponin BII could significantly influence the levels of malondialdehyde (MDA) and glutathione (GSH), thereby restoring the insulin secretion ability and cell viability of model cells. Lipidomics analysis was combined with multivariate statistical analysis for marker selection. The four most common pathological and pharmacological lipid markers were phosphatidylserine (PS), suggesting that timosaponin BII had protective effects on model cells related to the reduction oxidative stress and macrophage inflammation. RAW264.7 macrophages were stimulated by LPS to establish a model of inflammation and study the effect of timosaponin BII on the nodes of NOD-like receptor P3 (NLRP3) inflammasome pathway in the model cells. In conclusion, timosaponin BII may have the effect of protecting INS-1 pancreatic ß cells through reducing IL-1ß (interleukin-1ß) production by inhibiting the NLRP3 inflammasome in macrophage and restoring the insulin secretion ability and cell viability by reducing oxidative stress.


Subject(s)
Anemarrhena/chemistry , Glycolipids/toxicity , Protective Agents/chemistry , Saponins/chemistry , Steroids/chemistry , Anemarrhena/metabolism , Animals , Cell Survival/drug effects , Discriminant Analysis , Glutathione/metabolism , Inflammation/metabolism , Inflammation/pathology , Inflammation/prevention & control , Insulin-Secreting Cells/cytology , Insulin-Secreting Cells/drug effects , Insulin-Secreting Cells/metabolism , Interleukin-1beta/metabolism , Lipidomics/methods , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Malondialdehyde/metabolism , Mice , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Nitric Oxide/metabolism , Oxidative Stress/drug effects , Principal Component Analysis , Protective Agents/pharmacology , Protective Agents/therapeutic use , RAW 264.7 Cells , Saponins/isolation & purification , Saponins/pharmacology , Saponins/therapeutic use , Steroids/isolation & purification , Steroids/pharmacology , Steroids/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL